Innatrix offers an automated protein evolution system for developing novel biocontrol agents against plant pathogens. Using soybean cyst nematode as proof-of-concept, the platform accelerates protein ligand optimization through continuous lab evolution, enabling rapid development of targeted crop protection solutions.
Innatrix has developed a proprietary, automated protein evolution platform designed to accelerate the discovery and optimization of protein ligands that can serve as novel biocontrol agents against plant pathogens. The system enables many generations of mutagenesis and binding selection per day in autonomous mode, running continuously for weeks. This dramatically shortens the timeline for developing targeted crop protection proteins compared to traditional methods. The platform is being validated using the soybean cyst nematode (SCN) virulence effector protein as a proof-of-concept target, with the goal of demonstrating that the system can produce optimized protein ligands capable of neutralizing this major agricultural pest.
Core capabilities:
Validation approach:
The protein evolution selection system has been confirmed working through multiple experiments, and the underlying intellectual property is close to patent award. Ligand optimization has already been demonstrated for T7 RNA polymerase as a model target. The current stage involves validating the full workflow against the soybean cyst nematode target, including target expression, ligand identification, optimization, and efficacy confirmation. The platform is positioned for collaborative validation with partners experienced in plant pathology and in planta assay development.
Innatrix is a North Carolina-based biotech company founded in 2012, specializing in sustainable biopesticides and innovative crop protection solutions.